BioSpace News Archive

Tempus, a leader in artificial intelligence and precision medicine, today announced results from validation studies demonstrating the reliable analytical performance of the Tempus|xF liquid biopsy

The Honourable Patty Hajdu, Minister of Health, announced five new projects receiving funding through the Immunization Partnership Fund to support vaccination efforts across Canada.

The National Disease Research Interchange, a world leader in the procurement and distribution of biospecimens to advance research, recognized Carolina Donor Services, an Organ Procurement Organization which serves 77 counties in North Carolina and Virginia, as the recipient of the third annual NDRI/AOPO Empowering Research and Discovery Award for outstanding commitment to the advancement of research.

Cambridge Diagnostic Imaging, CaDi, launches Lycobrain™, a first-in class nutraceutical to reboot and support brain functions, together with the development of a companion point-of-care diagnostic blood test for the assessment of tissue oxygenation.

The adenosine triphosphate (ATP) swab test market was valued at US$ 198.21 million in 2019 and is projected to reach US$ 369.71 million by 2027; it is expected to grow at a CAGR of 8.2%from 2020 to 2027.

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (“MustGrow”) is pleased to announce positive results from its non-exclusive floriculture trials (the “Carnation Trials”) in Colombia with Gowan Group (“Gowan”), a global, private family-owned agriculture solutions business specializing in developing, marketing, and manufacturing global agriculture inputs such as crop protection products, seeds and fertilizers

KCAS Bioanalytical and Biomarker Services, a laboratory services focused contract research organization is pleased to announce the expansion of their Biopharmaceutical Services team.

Syneos Health®, the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2021 financial results on Monday, August 9, 2021, prior to its earnings call at 8:00 a.m. ET.

Celldex Therapeutics, Inc. announced that it is proposing to offer and sell, subject to market conditions, $175 million of shares of its common stock in an underwritten public offering.

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, reported preliminary unaudited results for the second quarter of 2021.